K-2 300 mcg MK7
100/100
This product looks safe
- No ingredients exceed tolerable upper intake levels
- 50% of ingredients have research evidence
A
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Label Data
1 MicroLingual(R) Tablet(s)
Serving Size
60
Servings
Botanical with Nutrients
Product Type
50%
Evidence Coverage
Supplement Facts — Evidence Check
300 mcg
(375% DV)
✅ 2.5× RDA — within safe limits
📚 273 studies (Tier A: 9, B: 175)
Stevia leaf extract
2 mg
Other Ingredients
Lactose
Calcium Phosphate
Acacia Gum
Label Claims — Verification
❓
All Other
All Other (100% of products)
Structure/Function (84% of products)
Nutrient (73% of products)
Target Groups
Adult (18 - 50 Years)
Product Information
📋 Directions for Use
Directions: As a dietary supplement, dissolve one Microlingual tablet under the tongue as directed by your healthcare provider. This product may also be chewed/swallowed.
⚠️ Warnings & Precautions
Warnings: If you are currently taking any anti-coagulant drugs (warfarin, coumadin, heparin, i.e.) or if you are pregnant/lactating, consult your healthcare provider before consumption.
Keep out of the reach of children.
🧪 Formulation Notes
GMO free
Product Details
DSLD Entry Date
2020-01-25
Product Type
Botanical with Nutrients
Form
Tablet or Pill
Brand
Superior Source
DSLD ID
212707
Data Updated
2026-04-11
Research Evidence
332
Research Sources
59
Avg Quality Score
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A
Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
A
Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
A
Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
A
Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
A
Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
A
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
A
Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
A
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Compare Similar Products
Vitamin K 100 mcg
Vitamin World
100
Vitamin K2
Higher Nature
100
Vitamin K-1
The Vitamin Shoppe
100
Vitamin K1 100 mcg
The Vitamin Shoppe
100
Vitamin K1 100 mcg
Country Life
100